Castellan Group Mckesson Corp Transaction History

Castellan Group

$236 Million
Q3 2024

A detailed history of Castellan Group transactions in Mckesson Corp stock. As of the latest transaction made, Castellan Group holds 10,200 shares of MCK stock, worth $5.91 Million. This represents 2.14% of its overall portfolio holdings.

Number of Shares

10,200

Previous 9,809 3.99%

Holding current value

$5.91 Million

Previous $5.73 Million 12.01%

% of portfolio

2.14%

Previous 2.86%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 25, 2024	BUY	$479.06 - $630.38 $187,312 - $246,478	391 Added 3.99%	10,200 $5.04 Million
Q2 2024 Aug 09, 2024	BUY	$518.81 - $607.81 $304,022 - $356,176	586 Added 6.35%	9,809 $5.73 Million
Q1 2024 May 15, 2024	BUY	$473.42 - $539.26 $396,252 - $451,360	837 Added 9.98%	9,223 $4.95 Million
Q3 2023 Nov 14, 2023	SELL	$402.4 - $446.42 $617,684 - $685,254	-1,535 Reduced 15.47%	8,386 $3.65 Million
Q2 2023 Aug 14, 2023	SELL	$354.01 - $427.31 $244,974 - $295,698	-692 Reduced 6.52%	9,921 $4.24 Million
Q1 2023 May 17, 2023	SELL	$335.35 - $386.06 $85,514 - $98,445	-255 Reduced 2.35%	10,613 $3.78 Million
Q4 2022 Feb 16, 2023	SELL	$346.68 - $397.58 $19,414 - $22,264	-56 Reduced 0.51%	10,868 $4.08 Million
Q3 2022 Nov 15, 2022	SELL	$321.25 - $373.84 $387,748 - $451,224	-1,207 Reduced 9.95%	10,924 $3.71 Million
Q2 2022 Aug 15, 2022	BUY	$300.57 - $336.42 $125,037 - $139,950	416 Added 3.55%	12,131 $3.71 Million
Q2 2022 Aug 15, 2022	SELL	$300.57 - $336.42 $125,037 - $139,950	-416 Reduced 3.43%	11,715 $3.82 Million
Q1 2022 May 23, 2022	BUY	$244.61 - $310.48 $2.97 Million - $3.77 Million	12,131 New	12,131 $3.71 Million

Others Institutions Holding MCK

# of Institutions

1,690

Shares Held

108M

Call Options Held

1.66M

Put Options Held

968K

View Full List

About MCKESSON CORP

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $83.3B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

More about MCK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Castellan Group, based on Form 13F filings with the SEC.

News

Stay updated on Castellan Group with notifications on news.

Account